Tag: #respiratorydisease

Merck Acquires Verona Pharma for $10 Billion to Expand Respiratory Treatments

Merck & Co. will acquire Verona Pharma for $10 billion to strengthen its respiratory treatment portfolio with innovative COPD therapy.

#merck, #veronapharma, #acquisition, #healthcare, #respiratorydisease

Merck Acquires Verona Pharma for $10 Billion to Boost Respiratory Portfolio

Merck acquires UK-based Verona Pharma for $10B, enhancing its respiratory treatments ahead of Keytruda's 2028 patent expiration.

#merck, #veronapharma, #acquisition, #pharmaceuticals, #respiratorydisease